Simon Fletcher is a highly motivated and innovative scientist with 25 years of experience in virology and drug discovery. Currently serving as Vice President at Gilead Sciences, Simon leads a team dedicated to developing novel treatments for various hepatitis viruses, SARS-CoV-2, and other infectious agents. Previous roles include positions as Executive Director, Director of Biology, and Principal Scientist at Gilead Sciences, as well as significant contributions at Roche and Anadys Pharmaceuticals. Simon earned a Ph.D. in Virology and a First Class BA (Hons) in Natural Sciences from the University of Cambridge.
This person is not in the org chart
This person is not in any teams
This person is not in any offices